Leukemia-Lymphoma, Adult T-Cell
Showing 9951 - 9975 of >10,000
Lung Non-Small Cell Carcinoma Trial in Buffalo (Pembrolizumab)
Active, not recruiting
- Lung Non-Small Cell Carcinoma
- Pembrolizumab
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 27, 2023
Human Papillomavirus, HPV-16, High Grade Squamous Intraepithelial Lesion Trial run by the NCI (Aldesleukin, E6 T Cell Receptor
Terminated
- Human Papillomavirus
- +2 more
- Aldesleukin
- E6 T Cell Receptor (TCR)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 1, 2021
Low Back Pain Trial in Szeged (survey)
Active, not recruiting
- Low Back Pain
- survey
-
Szeged, Csongrád-Csanád, HungaryUniversity of Szeged
Aug 3, 2022
Multiple Myeloma, Refractory Multiple Myeloma Trial in Houston (Digital Health Coaching Program, Fitbit)
Recruiting
- Multiple Myeloma
- Refractory Multiple Myeloma
- Digital Health Coaching Program
- Fitbit
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jun 17, 2022
Melanoma and Sarcoma Trial in London (Talimogene laherparepvec (T-VEC))
Completed
- Melanoma and Sarcoma
- Talimogene laherparepvec (T-VEC)
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Aug 17, 2021
Cellular Immunity and Renal Cell Cancer
Completed
- NK Cell Mediated Immunity
- +2 more
-
Rijeka, CroatiaClinical Hospital Center Rijeka
Sep 19, 2021
Difficult Airway and Ultrasonographic Evaluation
Completed
- Difficult Airway
- difficult airway
-
Kocaeli̇, TurkeyKocaeli Üniversitesi
Apr 21, 2022
NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)
Recruiting
- NSCLC
- SBRT+LDRT
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Apr 2, 2023
MeMed BV® Test Evaluation in Adult Emergency Department Patients
Not yet recruiting
- Respiratory Infection
- +3 more
- MeMed BV® test
- (no location specified)
Feb 6, 2023
Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)
Recruiting
- Leukemia, Myeloid, Acute
- Liposomal Annamycin
- Cytarabine
-
Bologna, Italy
- +4 more
Jan 31, 2023
Healthy Trial in San Antonio (Tolperisone)
Completed
- Healthy
-
San Antonio, TexasWorldwide Clinical Trials Early Phase Services, LLC
Jan 28, 2022
Prostate Cancer Trial in Madison (Degarelix, pTVG-AR, Nivolumab)
Recruiting
- Prostate Cancer
- Degarelix
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jul 6, 2022
Advanced Esophageal Squamous Cell Carcinoma Trial in China (TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin,
Not yet recruiting
- Advanced Esophageal Squamous Cell Carcinoma
- TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin
- +2 more
-
Tongling, Anhui, China
- +9 more
Apr 18, 2023
Type 1 Diabetes Trial in Toronto, Vancouver (Ustekinumab, Placebo)
Recruiting
- Type 1 Diabetes Mellitus
- Ustekinumab
- Placebo
-
Toronto, British Columbia, Canada
- +1 more
Jun 3, 2022
Genes in Samples From Limited or Advanced Diffuse Large B-Cell
Completed
- Lymphoma
- RNA analysis
- +3 more
- (no location specified)
Dec 18, 2019
Covid19 Trial in Canada, United States (Low Dose of KBP-COVID-19, High Dose of KBP-COVID-19, Placebo)
Active, not recruiting
- Covid19
- Low Dose of KBP-COVID-19
- +2 more
-
West Palm Beach, Florida
- +7 more
Aug 15, 2022
Stress, Behavior Trial in Madison (mHealth Meditation)
Recruiting
- Stress
- Behavior
- mHealth Meditation
-
Madison, WisconsinCenter for Healthy Minds
Aug 12, 2022
Esophageal Cancer, Metastatic Cancer, Squamous Cell Carcinoma Trial in Taipei City (Cabozantinib 40 MG, Atezolizumab Injection)
Recruiting
- Esophageal Cancer
- +2 more
- Cabozantinib 40 MG
- Atezolizumab Injection
-
Taipei City, TaiwanNational Taiwan University Hospital
Sep 15, 2022
ACUTE LEUKEMIA Trial in Madrid (Donor IL-15 stimulated NK cells infusion)
Completed
- ACUTE LEUKEMIA
- Donor IL-15 stimulated NK cells infusion
-
Madrid, SpainHospital General Universitario Gregorio Marañón
Sep 2, 2021
Chronic Fatigue Syndrome Trial in Oslo (Interdisciplinary complex intervention)
Recruiting
- Chronic Fatigue Syndrome
- Interdisciplinary complex intervention
-
Oslo, NorwayOslo University Hospital
Dec 23, 2021
Pulmonary Arterial Hypertension Trial in Kansas City (Placebo, Seralutinib, Generic Dry Powder Inhaler)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Placebo
- +2 more
-
Kansas City, KansasUniversity of Kansas Medical Center
Jun 28, 2023
Atopic Dermatitis, Eczema Trial in Cincinnati (Dupilumab Prefilled Syringe)
Recruiting
- Atopic Dermatitis
- Eczema
- Dupilumab Prefilled Syringe
-
Cincinnati, OhioBernstein Clinical Research Center
Feb 28, 2022
Insomnia Disorder Trial in Worldwide (Daridorexant 10 mg, Daridorexant 25 mg, Daridorexant 50 mg)
Completed
- Insomnia Disorder
- Daridorexant 10 mg
- +3 more
-
Birmingham, Alabama
- +105 more
Feb 7, 2022